The aim of the present study was to evaluate the effect of short-term adrenergic blockade on the rate of whole-body protein turnover and leucine oxidation, and on protein synthesis in specific tissues in male rats. Adrenergic blockade was induced by guanethidine (100 mg/kg body weight subcutaneously). The control group was treated with saline. On the second day, the parameters of whole-body protein and leucine metabolism were evaluated using a primed constant intravenous infusion of L-[1-(14)C]leucine. Protein synthesis in tissues was determined on the basis of L-[1-(14)C]leucine incorporation. Guanethidine treatment caused a decrease in norepinephrine in skeletal muscle. Whole-body leucine oxidation and leucine oxidized fraction were higher in guanethidine-treated rats. There was an insignificant effect of guanethidine on whole-body proteolysis, protein synthesis and leucine clearance. However, protein balance was negative due to the larger difference between protein synthesis and proteolysis in guanethidine-treated animals compared to controls. In guanethidine-treated rats, protein synthesis was higher in the gastrocnemius muscle and in the kidneys and lower in liver and spleen. Changes in the small intestine and colon were insignificant. In addition, a marked decrease in concentration of several amino acids has been observed in the liver, the kidneys and the spleen. It is concluded that adrenergic blockade induced by guanethidine is associated with significant changes in protein metabolism, leucine oxidation and amino acid concentrations in several tissues. The most important consequences of treatment are considered to be a negative effect on protein balance, increased protein turnover in skeletal muscle and kidneys and decreased protein synthesis in the liver and spleen. These changes may also be induced by administration of other sympathetic blocking agents, e.g. in treatment of hypertension.

Department of Physiology Charles University School of Medicine Hradec Králové Czech Republic

Zobrazit více v PubMed

Anthony JC, Yoshizawa F, Anthony TG, Vary TC, Jefferson LS, Kimball SR. Leucine stimulates translation initiation in skeletal muscle of postabsorptive rats via a rapamycin-sensitive pathway. J. Nutr. 2000;130:2413–2419. PubMed

Benson JR, Hare P. o-Phtalaldehyde: fluorogenic detection of primary amines in the picomole range. Comparison with fluorescamine and ninhydrin. Proc. Natl. Acad. Sci. USA. 1975;72:619–622. PubMed PMC

Bielavská M, Kassa J. Simultaneous determination of dopamine, serotonine and their metabolites in the rat brain by HPLC method with coulometric detection. Collect. Czech. Chem. Commun. 2000;65:1677–1682.

Chance WT, Cao P, Zhang FS, Fischer JE. Clenbuterol plus acivicin decrease tumor growth and increase muscle mass in rats maintained on total parenteral nutrition. Am. J. Surg. 1991;161:51–56. PubMed

Costelli P, Garcia-Martinez C, Llovera M, et al. Muscle protein waste in tumor-bearing is effectively antagonized by β2-adrenergic agonist (clenbuterol). Role of the ATP-ubiquitin dependent proteolytic pathway. J. Clin. Invest. 1995;95:2367–2372. PubMed PMC

Davies JW, Hall TC. Liquid scintillation counting methods for accurate assay of beta radioactivity in biological experiments. Anal. Biochem. 1969;27:77–90. PubMed

De Bandt JP, Cynober LA. Amino acids with anabolic properties. Curr. Opin. Clin. Nutr. Metab. Care. 1998;1:263–272. PubMed

Finley RJ, Inculet RI, Pace R, et al. Major operative trauma increases peripheral amino acid release during the steady-state infusion of total parenteral nutrition in man. Surgery. 1986;99:491–500. PubMed

Greiwe JS, Kwon G, McDaniel ML, Semenkovich CF. Leucine and insulin activate p70 S6 kinase through different pathways in human skeletal muscle. Am. J. Physiol. 2001;281:E466–E471. PubMed

Guyton AC, Hall JE. Textbook of Medical Physiology. 9. Philadelphia, PA: W.B. Saunders Company; 1996. The autonomic nervous system; the adrenal medulla; pp. 769–781.

Holeček M. Relation between glutamine, branched-chain amino acids, and protein metabolism. Nutrition. 2002;18:130–133. PubMed

Holeček M, Šprongl L, Skopec F, Andrýs C, Pecka M. Leucine metabolism in TNF-α- and endotoxin-treated rats: contribution of hepatic tissue. Am. J. Physiol. 1997;273:E1052–E1058. PubMed

Kim YS, Sainz RD. β-Adrenergic agonists and hypertrophy of skeletal muscles. Life Sci. 1991;50:397–407. PubMed

Lamont LS, Patel DG, Kalhan SC. Beta-adrenergic blockade alters whole-body leucine metabolism in humans. J. Appl. Physiol. 1989;67:221–225. PubMed

Lowry OH, Rosebrough AL, Farr AL, Randal R. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951;193:265–275. PubMed

McCarty ME, Grossi EA, Cutting C, Prevel CD, Elluru R, Eppley BL. Sympathetic blockade of isolated rat hindlimbs by intra-arterial guanethidine: the effect on blood flow and arterial-venous shunting. Microsurgery. 1995;16:476–481. PubMed

McElligott MA, Mulder JE, Chuang L-Y. Clenbuterol-induced muscle growth; investigation of possible mediation by insulin. Am. J. Physiol. 1987;253:E370–E375. PubMed

Navegantes LC, Resano NMZ, Migliorini RH, Kettelhut IC. Effect of guanethidine-induced adrenergic blockade on the different proteolytic systems in rat skeletal muscle. Am. J. Physiol. 1999;277:E883–E889. PubMed

Navegantes LC, Resano NMZ, Migliorini RH, Kettelhut IC. Role of adrenoceptors and camp on the catecholamines-induced inhibition of proteolysis in rat skeletal muscle. Am. J. Physiol. 2000;279:E663–E668. PubMed

Picklo MJ. Methods of sympathetic degeneration and alteration. J. Auton. Nerv. Syst. 1997;62:111–125. PubMed

Reeds PJ, Hay SM, Dorwood PM. Stimulation of muscle growth by clenbuterol: lack of effect on muscle protein synthesis. Br. J. Nutr. 1986;56:249–258. PubMed

Walker CD. Chemical sympathectomy and maternal separation affect neonatal stress responses and adrenal sensitivity to ACTH. Am. J. Physiol. 1995;268:R1281–R1288. PubMed

Zeman RJ, Ludemann R, Etlinger JD. Clenbuterol a β2-agonist, retards atrophy in denervated muscles. Am. J. Physiol. 1987;252:E152–E155. PubMed

Žižkovsky̌ V. Legal aspects in the Czech Republic. In: Červinka M, Balls M, editors. Alternatives to Animal Experimentation. Hradec Králové: Nukleus; 1994. pp. 23–24.